-
Diquafosol (tradename Diquas) is a
pharmaceutical drug for the
treatment of dry eye disease. It was
approved for use in ****an in 2010. It is formulated...
- β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768 MRS-2957...
- β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768 MRS-2957...
- β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768 MRS-2957...
- β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768 MRS-2957...
- β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768 MRS-2957...
- β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768 MRS-2957...
- β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768 MRS-2957...
- cancer.
Cheaper generic alternatives are
available in some countries.
Diquafosol, an
agonist of the P2Y2
purinergic receptor, is
approved in ****an for...
- β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768 MRS-2957...